H. Collins-Hooper
Propeptide-mediated inhibition of myostatin increases muscle mass through inhibiting proteolytic pathways in aged mice
Collins-Hooper, H.; Sartori, R.; Macharia, R.; Visanuvimol, K.; Foster, K.; Flasskamp, H.; Ray, S.; Dash, P. R.; Sandri, M.; Patel, K.; Collins-Hooper, Henry; Sartori, Roberta; Macharia, Raymond; Visanuvimol, Korntip; Foster, Keith; Matsakas, Antonios; Flasskamp, Hannah; Ray, Steve; Dash, Philip R.; Sandri, Marco; Patel, Ketan
Authors
R. Sartori
R. Macharia
K. Visanuvimol
K. Foster
H. Flasskamp
S. Ray
P. R. Dash
M. Sandri
K. Patel
Henry Collins-Hooper
Roberta Sartori
Raymond Macharia
Korntip Visanuvimol
Keith Foster
Dr Antonios Matsakas A.Matsakas@hull.ac.uk
Senior Lecturer in Biomedical Sciences
Hannah Flasskamp
Steve Ray
Philip R. Dash
Marco Sandri
Ketan Patel
Abstract
Mammalian aging is accompanied by a progressive loss of skeletal muscle, a process called sarcopenia. Myostatin, a secreted member of the transforming growth factor-β family of signaling molecules, has been shown to be a potent inhibitor of muscle growth. Here, we examined whether muscle growth could be promoted in aged animals by antagonizing the activity of myostatin through the neutralizing activity of the myostatin propeptide. We show that a single injection of an AAV8 virus expressing the myostatin propeptide induced an increase in whole body weights and all muscles examined within 7 weeks of treatment. Our cellular studies demonstrate that muscle enlargement was due to selective fiber type hypertrophy, which was accompanied by a shift toward a glycolytic phenotype. Our molecular investigations elucidate the mechanism underpinning muscle hypertrophy by showing a decrease in the expression of key genes that control ubiquitin-mediated protein breakdown. Most importantly, we show that the hypertrophic muscle that develops as a consequence of myostatin propeptide in aged mice has normal contractile properties. We suggest that attenuating myostatin signaling could be a very attractive strategy to halt and possibly reverse age-related muscle loss.
Citation
Collins-Hooper, H., Sartori, R., Macharia, R., Visanuvimol, K., Foster, K., Matsakas, A., Flasskamp, H., Ray, S., Dash, P. R., Sandri, M., & Patel, K. (2014). Propeptide-mediated inhibition of myostatin increases muscle mass through inhibiting proteolytic pathways in aged mice. The journals of gerontology. Series A, Biological sciences and medical sciences, 69(9), 1049-1059. https://doi.org/10.1093/gerona/glt170
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 16, 2013 |
Online Publication Date | Jan 11, 2014 |
Publication Date | Sep 1, 2014 |
Deposit Date | May 21, 2015 |
Publicly Available Date | May 21, 2015 |
Journal | Journals of gerontology : series A |
Print ISSN | 1079-5006 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 69 |
Issue | 9 |
Pages | 1049-1059 |
DOI | https://doi.org/10.1093/gerona/glt170 |
Keywords | Muscle, Myostatin, Aging, Mouse, Sarcopenia |
Public URL | https://hull-repository.worktribe.com/output/374119 |
Publisher URL | http://biomedgerontology.oxfordjournals.org/content/69/9/1049 |
Additional Information | Copy of article first published in: Journals of gerontology : series A, 2014, v.69, issue 9. |
Contract Date | May 21, 2015 |
Files
Article.pdf
(6.8 Mb)
PDF
Copyright Statement
© The Author 2014. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved.
You might also like
PGC1β activates an antiangiogenic program to repress neoangiogenesis in muscle ischemia
(2014)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search